Questions and Answers
- Europe
Q: What value do you see in quantitative/centiloid versus visual “categorical” assessment of amyloid PET scans?
- USA
Q: What is the added value of CL scale in clinical practice?
Answered by: Dr Ana Franceschi
- Asia
Q: What are your suggestions for the order of NM neuroimaging for dementia and movement disorder? For example, should they start with FDG/brain perfusion SPECT first then amyloid or vice versa in dementia, or FDG/brain then DaT/MIBG scan or vice versa.
- Europe
Q: What do you believe will be the main indications for tau PET in the clinical setting in the near future?
Answered by: Prof Alexander Drzezga
- 2 comments